We’re delighted to welcome Lisa Huddlestone, PhD to the team as a Research Analyst and Zinc NIHR Innovation Fellow!

Lisa holds a PhD in Epidemiology and Public Health from the University of Nottingham and brings over a decade of experience in developing and evaluating technologies to improve both physical and mental health outcomes.

Her expertise in participatory and user-centred research, systematic evidence synthesis, and translating findings into actionable solutions will be invaluable as we continue our journey to bring the Callavid® drug delivery platform from bench to bedside.

Welcome, Lisa great to have you on board! 🚀

Thank you to Zinc, NIHR and Vivensa Foundation for having us be part of this year’s cohort.